Skip to main content

Advertisement

Figure 1 | BMC Cancer

Figure 1

From: LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells

Figure 1

Dose-response curves for single 5-FU and LY294002 treatments of AGS and SNU-719 gastric cancer cell lines. Dose-dependent inhibition of cell proliferation by 5-FU and LY294002 in gastric cancer cells. Cells were treated with increasing concentrations of 5-FU (A) or LY294002 (B) for 72 h, and the viable cells were quantified by MTS assay. The data presented are the mean ± SD of three independent experiments.

Back to article page